Study: PET/MRI shows promise in restaging of prostate cancer

12/26/2012 | AuntMinnie.com (free registration)

Choline-PET/MRI identified more suspicious lesions compared with PET/CT in 31 patients with recurrent prostate cancer, according to a study presented at a radiology meeting. The study also found that PET/MRI performs comparably with PET/CT in identifying lymph node metastases and bone metastases. The findings indicate a fully diagnostic choline-PET/MRI protocol for restaging prostate cancer is well-tolerated and feasible in patients, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC